CompletedNCT00314184
What is this study about?This study evaluated the safety and effectiveness of quetiapine fumarate for people with bipolarity.
This study has finished and is no longer accepting participants.
Multiple locations, including CerritosBipolarityMedication studyAges 18+
- Countries
- United States, Argentina, Bulgaria, + 12 others
- Sponsor
- AstraZeneca
CompletedNCT00223249
Official study titleA Randomized, Double-Blind, Placebo-Controlled Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Alcohol Abuse/ Dependence.
This study has finished and is no longer accepting participants.
In DallasBipolarityMedication studyAges 18–70
- Countries
- United States
- Sponsor
- University of Texas Southwestern Medical Center
CompletedNCT00428298
Official study titleA Double Blind Placebo Controlled Study of Valacyclovir in Cognitive Impairment and Mood Symptoms of Bipolar Disorder
This study has finished and is no longer accepting participants.
In BaltimoreBipolarityMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Johns Hopkins University
CompletedNCT01503489
Official study titleRisk for Antidepressant-associated Switch From Depression to Hypomania, Mania, or Mixed Episode During the 8 Weeks After the Introduction of an Antidepressant or After Increasing the Dosage of Baseline Antidepressant.
This study has finished and is no longer accepting participants.
In BarcelonaBipolarityObservational studyAges 18–80
- Countries
- Spain
- Sponsor
- Hospital Clinic of Barcelona
CompletedNCT00499096
Official study titleCardiovascular Risk Factors in Veterans With Bipolar Disorder
This study has finished and is no longer accepting participants.
In Ann ArborBipolarityBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- US Department of Veterans Affairs
CompletedNCT00501865
Official study titleAn Open, Randomised, Two-period Crossover Study to Investigate the Effect of Food on the Pharmacokinetics of GW273225 Administered Immediately After Food and Administered in Fasted State to Healthy Male and Female Subjects
This study has finished and is no longer accepting participants.
In CambridgeBipolarityMedication studyAges 18–55
- Countries
- United Kingdom
- Sponsor
- GlaxoSmithKline
CompletedNCT00259272
Official study titlePhase IIIb, Multicenter, Single-Arm Open-Label Study, Supporting the Development and the Validation of the MATHYS Scale (Multidimensional Assessment of THYmic States) in a Population of Bipolar Patients Treated With Olanzapine, Either in-Label (Manic and Mixed Patients) and Off-Label (Hypomanic and Bipolar Depression)
This study has finished and is no longer accepting participants.
Multiple locations, including AndillyBipolarityMedication studyAges 18+
- Countries
- France
- Sponsor
- Eli Lilly and Company
CompletedNCT03266679
Official study titleBipolar Mood Disorders: A Recovery-Oriented Intervention Approach Addressing Deficits In Metacognitive Capacities
This study has finished and is no longer accepting participants.
In BrisbaneBipolarityInterventional study
- Countries
- Australia
- Sponsor
- Queensland University of Technology